4.7 Article

Sensitive amperometric biosensors for detection of glucose and cholesterol using a platinum/reduced graphene oxide/poly(3-aminobenzoic acid) film-modified screen-printed carbon electrode

Journal

BIOELECTROCHEMISTRY
Volume 127, Issue -, Pages 125-135

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.bioelechem.2019.01.008

Keywords

Glucose biosensor; Cholesterol biosensor; Platinum; Reduced graphene oxide; Screen printed carbon electrode; Electrodeposition

Funding

  1. Science Achievement Scholarship of Thailand (SAST)
  2. National Nanotechnology Center (NANOTEC), the National Science and Technology Development Agency (NSTDA). Thailand
  3. Chiang Mai University

Ask authors/readers for more resources

A facile one-step electrochemical synthesis of a platinum/reduced graphene oxide/poly(3-aminobenzoic acid) (Pt/rGO/P3ABA) nanocomposite film on a screen-printed carbon electrode (SPCE) and its application in the development of sensitive amperometric biosensors was successfully demonstrated herein. The electropolymerization of P3ABA together with co-electrodeposition of rGO and Pt was conducted by cyclic voltammetry, as was the GO reduction to rGO. A Pt/rGO/P3ABA-modified SPCE exhibited excellent electrocatalytic oxidation towards hydrogen peroxide (H2O2) and can be employed as an electrochemical platform for the immobilization of glucose oxidase (GOx) and cholesterol oxidase (ChOx) to fabricate glucose and cholesterol biosensors, respectively. Under the optimized conditions at a working potential of +0.50 V, the proposed biosensors revealed excellent linear responses to glucose and cholesterol in the concentration ranges of 0.25-6.00 mM and 0.25-4.00 mM, respectively, with high sensitivities of 22.01 and 15.94 mu A mM(-1) cm(-2) and low detection limits (LODs) of 44.3 and 40.5 mu M. Additionally, the Michaelis-Menten constant (K-m) of GOx was 3.54 mM, while the K-m of ChOx was 3.82 mM. Both biosensors displayed a good anti-interference ability and clearly exhibited acceptable recoveries for the detection of glucose and cholesterol in a human serum sample (98.2-104.1%). (C) 2019 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available